Clinical Trial Update: Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating cyclophosphamide for refractory proliferative arachnoiditis in CNS tuberculosis is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arachnoiditis Tuberculous
• Tuberculosis
• Tuberculous Meningitis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Tuberculosis, Tubercular Meningitis | Phase 2, Phase 3 | Status: UNKNOWN